Leerink Partnrs Predicts Gilead Sciences Q1 Earnings
Equities researchers at Leerink Partnrs issued their Q1 2025 earnings per share estimates for Gilead Sciences in a report ...
Certara, Inc. (CERT): Among the Health Information Services Stocks Outpacing the Market in 2025
We recently published an article titled Top 10 Health Information Services Stocks Outpacing The Market In 2025. In this ...
Leerink Partnrs Cuts Earnings Estimates for Encompass Health
Stock analysts at Leerink Partnrs dropped their Q2 2025 earnings estimates for shares of Encompass Health in a note issued to investors on Tuesday, February 11th. Leerink Partnrs analyst W. Mayo now ...
Fate Therapeutics to Present at Upcoming Investor Conferences
Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class ...
Doximity, Inc. (DOCS): Among the Health Information Services Stocks Outpacing the Market in 2025
We recently published an article titled Top 10 Health Information Services Stocks Outpacing The Market In 2025. In this ...
MassDevice23h
Neuromod developer NeuroPace announces $65M offering
NeuroPace (Nasdaq:NPCE) today announced that it intends to sell common stock in an underwritten public offering worth $65 ...
Crain's New York15h
Drugmakers step back from diversity pledges in bow to Trump
Last year, Bristol Myers Squibb devoted half a page of its annual report to its diversity, equity and inclusion efforts, ...
Elanco stock touches 52-week low at $11.11 amid market challenges
Incorporated (NYSE: ELAN) shares have reached a 52-week low, dipping to $11.11, as the company faces a tumultuous market environment. With a market capitalization of $5.55 billion and a beta of 1.42, ...